Journal of Biological Chemistry · 2003 · 363 citations · 42 references
Life SciencesMolecular BiologyNeuroscienceGene ExpressionMolecular NeurobiologyMolecular NeuroscienceMolecular Basis Of NeurodegenerationNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseParkinsonian DisordersProtein DegradationDopaminergic NeurodegenerationDopaminergic Neuron DeathEndoplasmic Reticulum StressEndoplasmic Reticulum Stress ResponsesEr Stress SensorsUbiquitin-proteasome System DysfunctionUnfolded Protein ResponseUnfolded Protein Response Genes
Genes associated with Parkinson's disease (PD) have suggested a role for ubiquitin-proteasome dysfunction and aberrant protein degradation in this disorder. Inasmuch as oxidative stress has also been implicated in PD, the present study examined transcriptional changes mediated by the Parkinsonism-inducing neurotoxins 6-hydroxydopamine (6-OHDA) and 1-methyl-4-phenylpyridinium (MPP+) in a dopaminergic cell line. Microarray analysis of RNA isolated from toxin treated samples revealed that the stress-induced transcription factor CHOP/Gadd153 was dramatically up-regulated by both 6-OHDA and MPP+. Treatment with 6-OHDA also induced a large number of genes involved in endoplasmic reticulum stress and unfolded protein response (UPR) such as ER chaperones and elements of the ubiquitin-proteasome system. Reverse transcription-PCR, Western blotting, and immunocytochemical approaches were used to quantify and temporally order the UPR pathways involved in neurotoxin-induced cell death. 6-OHDA, but not MPP+, significantly increased hallmarks of UPR such as BiP, c-Jun, and processed Xbp1 mRNA. Both toxins increased the phosphorylation of UPR proteins, PERK and eIF2α, but only 6-OHDA increased phosphorylation of c-Jun. Thus, 6-OHDA is capable of triggering multiple pathways associated with UPR, whereas MPP+ exhibits a more restricted response. The involvement of UPR in these widely used neurotoxin models supports the role of ubiquitin-proteasome pathway dysfunction in PD. Genes associated with Parkinson's disease (PD) have suggested a role for ubiquitin-proteasome dysfunction and aberrant protein degradation in this disorder. Inasmuch as oxidative stress has also been implicated in PD, the present study examined transcriptional changes mediated by the Parkinsonism-inducing neurotoxins 6-hydroxydopamine (6-OHDA) and 1-methyl-4-phenylpyridinium (MPP+) in a dopaminergic cell line. Microarray analysis of RNA isolated from toxin treated samples revealed that the stress-induced transcription factor CHOP/Gadd153 was dramatically up-regulated by both 6-OHDA and MPP+. Treatment with 6-OHDA also induced a large number of genes involved in endoplasmic reticulum stress and unfolded protein response (UPR) such as ER chaperones and elements of the ubiquitin-proteasome system. Reverse transcription-PCR, Western blotting, and immunocytochemical approaches were used to quantify and temporally order the UPR pathways involved in neurotoxin-induced cell death. 6-OHDA, but not MPP+, significantly increased hallmarks of UPR such as BiP, c-Jun, and processed Xbp1 mRNA. Both toxins increased the phosphorylation of UPR proteins, PERK and eIF2α, but only 6-OHDA increased phosphorylation of c-Jun. Thus, 6-OHDA is capable of triggering multiple pathways associated with UPR, whereas MPP+ exhibits a more restricted response. The involvement of UPR in these widely used neurotoxin models supports the role of ubiquitin-proteasome pathway dysfunction in PD. Parkinson's disease (PD) 1The abbreviations used are: PD, Parkinson's disease; 6-OHDA, 6-hydroxydopamine; MPP+, 1-methyl-4-phenylpyridinium; UPR, unfolded protein response; RT, reverse transcription; ER, endoplasmic reticulum; MPTP, N-methyl-4-phenyl-1,2,3,6-tetrahydroyridine; PBS, phosphate-buffered saline; PERK, PKR-like ER kinase; SAPK, stress-activated protein kinase; JNK, c-Jun N-terminal kinase; ANOVA, analysis of variance; TH, tyrosine hydroxylase; eIF, eukaryotic initiation factor.1The abbreviations used are: PD, Parkinson's disease; 6-OHDA, 6-hydroxydopamine; MPP+, 1-methyl-4-phenylpyridinium; UPR, unfolded protein response; RT, reverse transcription; ER, endoplasmic reticulum; MPTP, N-methyl-4-phenyl-1,2,3,6-tetrahydroyridine; PBS, phosphate-buffered saline; PERK, PKR-like ER kinase; SAPK, stress-activated protein kinase; JNK, c-Jun N-terminal kinase; ANOVA, analysis of variance; TH, tyrosine hydroxylase; eIF, eukaryotic initiation factor. involves an irreversible degeneration of the dopaminergic nigrostriatal pathway, resulting in marked impairments of motor control. Although the etiology of PD remains unknown, both genetic and environmental factors appear to play a role. For example, three genes and several putative loci have been identified (1Lansbury P. Brice A. Curr. Opin. Cell Biol. 2002; 14: 653Crossref PubMed Scopus (61) Google Scholar), including two autosomal dominant mutations of the α-synuclein gene, that were linked to rare familial early-onset PD (2Polymeropoulos M.H. Lavedan C. Leroy E. Ide S.E. Dehejia A. Dutra A. Pike B. Root H. Rubenstein J. Boyer R. Stenroos E.S. Chandrasekharappa S. Athanassiadou A. Papapetropoulos T. Johnson W.G. Lazzarini A.M. Duvoisin R.C. Di Iorio G. Golbe L.I. Nussbaum R.L. Science. 1997; 276: 2045-2047Crossref PubMed Scopus (6556) Google Scholar, 3Kreuger R. Kuhn W. Meuller T. Woitalla D. Graeber M. Keosel S. Przuntek H. Epplen J.T. Scheols L. Riess O. Nat. Genet. 1998; 18: 106-108Crossref PubMed Scopus (3280) Google Scholar). α-Synuclein was subsequently shown to be the major component of Lewy bodies, the hallmark inclusion of PD (4Spillantini M.G. Schmidt M.L. Lee V.M. Trojanowski J.Q. Jakes R. Goedert M. Nature. 1997; 388: 839-840Crossref PubMed Scopus (6037) Google Scholar). Parkin, a second gene with mutations associated with PD (5Kitada T. Asakawa S. Hattori N. Matsumine H. Yamamura Y. Minoshima S. Yokochi M. Mizuno Y. Shimizu N. Nature. 1998; 392: 605-608Crossref PubMed Scopus (4140) Google Scholar), has been shown to be an ubiquitin-protein isopeptide ligase (6Shimura H. Hattori N. Kubo S. Mizuno Y. Asakawa S. Minoshima S. Shimizu N. Iwai K. Chiba T. Tanaka K. Suzuki T. Nat. Genet. 2000; 25: 302-305Crossref PubMed Scopus (1686) Google Scholar). Loss of Parkin activity is linked to endoplasmic reticulum (ER) stress and unfolded protein response (UPR; Refs. 7Imai Y. Soda M. Hatakeyama S. Akagi T. Hashikawa T. Nakayama K.I. Takahashi R. Mol. Cell. 2002; 10: 55-67Abstract Full Text Full Text PDF PubMed Scopus (422) Google Scholar and 8Imai Y. Soda M. Inoue H. Hattori N. Mizuno Y. Takahashi R. Cell. 2001; 105: 891-902Abstract Full Text Full Text PDF PubMed Scopus (920) Google Scholar). Finally, a missense mutation in the gene encoding ubiquitin C-terminal hydrolase L1 is also associated with rare cases of PD (9Leroy E. Boyer R. Auburger G. Leube B. Ulm G. Mezey E. Harta G. Brownstein M.J. Jonnalagada S. Chernova T. Dehejia A. Lavedan C. Gasser T. Steinbach P.J. Wilkinson K.D. Polymeropoulos M.H. Nature. 1998; 395: 451-452Crossref PubMed Scopus (1372) Google Scholar). Thus, aggregation of α-synuclein together with defects in the ubiquitin pathway support the notion that a dysfunctional ubiquitin-proteasome system in which aberrant proteins are not cleared may play a major role in PD. The role of proteasomal impairment has been further emphasized by recent reports that pharmacological inhibition of proteasome function leads to selective degeneration of dopaminergic neurons in culture (10McNaught K.S. Mytilineou C. Jnobaptiste R. Yabut J. Shashidharan P. Jennert P. Olanow C.W. J. Neurochem. 2002; 81: 301-306Crossref PubMed Scopus (270) Google Scholar) as well as in vivo (11McNaught K.S. Bjeorklund L.M. Belizaire R. Isacson O. Jenner P. Olanow C.W. Neuroreport. 2002; 13: 1437-1441Crossref PubMed Scopus (231) Google Scholar). In particular, cell death was associated with increased cytoplasmic levels of α-synuclein and ubiquitin, as well as the formation of inclusion bodies (10McNaught K.S. Mytilineou C. Jnobaptiste R. Yabut J. Shashidharan P. Jennert P. Olanow C.W. J. Neurochem. 2002; 81: 301-306Crossref PubMed Scopus (270) Google Scholar, 11McNaught K.S. Bjeorklund L.M. Belizaire R. Isacson O. Jenner P. Olanow C.W. Neuroreport. 2002; 13: 1437-1441Crossref PubMed Scopus (231) Google Scholar). Taken together, accumulating genetic and molecular evidence suggests that defects in ER and ubiquitin-proteasomal processing contribute to the pathogenesis of PD. Because PD is largely restricted to dopaminergic neurons and because dopamine is easily in and in vivo to a of dopamine is a major factor in this disorder. For example, dopamine is to three pathways J. PubMed Scopus Google Scholar). in the of and dopamine be to 6-OHDA D. S. N. M. R. 2001; PubMed Scopus Google Scholar), a neurotoxin widely used to models of PD D. S. N. M. R. 2001; PubMed Scopus Google Scholar). Both 6-OHDA and dopamine have been in M. B. J. J. PubMed Scopus Google Scholar, B. E. A. 25: PubMed Scopus Google Scholar, Jenner P. S.E. B. J. Neurochem. 1998; PubMed Scopus Google Scholar), a together with the the role dopamine in PD MPP+, is also to oxidative stress and S. 2002; PubMed Scopus Google Scholar). The that to in PD P. Science. PubMed Scopus Google Scholar) has been in models including S. 2002; PubMed Scopus Google Scholar). Thus, both 6-OHDA and MPP+ have been shown to and to as well as to and of this Refs. D. S. N. M. R. 2001; PubMed Scopus Google Scholar, S. 2002; PubMed Scopus Google Scholar, and Nat. 2001; PubMed Scopus Google Scholar). these the molecular by which these neurotoxins to genetic and pharmacological models ubiquitin-proteasome pathway dysfunction and protein aggregation has to be from this and have that 6-OHDA and MPP+ of cell death in the dopaminergic cell and D. S. N. M. R. 2001; PubMed Scopus Google Scholar, J. PubMed Scopus Google Scholar, J. J. PubMed Google Scholar). of such as and are in treated with 6-OHDA, but not with MPP+. the of cell death induced by both of cell death to be protein Y. S. M. PubMed Scopus Google Scholar, S. Lee PubMed Scopus Google Scholar). of gene in 6-OHDA dopaminergic cell death models have been this is a of the and of the involved as well as the in a genes a Thus, is the of gene involved in 6-OHDA MPP+ in response to 6-OHDA and MPP+, used analysis of RNA isolated from the dopaminergic cell P.J. A. PubMed Scopus Google Scholar) as a to pathways induced by these have been shown to of the dopaminergic cell from which were J. PubMed Scopus Google Scholar, J. J. PubMed Google Scholar, Y. S. M. PubMed Scopus Google Scholar, S. Lee PubMed Scopus Google Scholar, P.J. A. PubMed Scopus Google Scholar, J. Google Scholar). the and in response of the present study used in to Western blotting, and immunocytochemical to that 6-OHDA three pathways associated with ER stress and UPR, whereas MPP+ to only such The of UPR in these models of dopaminergic cell death of may function to the disease and supports the that in the ubiquitin-proteasome pathway play an role in PD. Cell the was from as J. J. PubMed Google Scholar). were with and in for and further a were with by for were in with and of of the culture was with the and were in were with for and with were in with in an with were to with to of Treatment and of Cell were a of in and treated was of 6-OHDA with in MPP+ cell was the as Y. S. M. PubMed Scopus Google Scholar). Microarray were a of in were treated with 6-OHDA MPP+, for RNA was isolated of neurotoxin an to the from the of RNA from three neurotoxin were together for of and RNA were of of RNA was to the J. for of and were by Microarray as well as for For both and in by the a of an was for which was of the were Reverse were and treated as for RNA was and to RNA PubMed Scopus Google Scholar) were used to of RNA in RNA was reverse reverse and resulting were used and in N. Mol. 1997; PubMed Scopus Google Scholar, and and and and were a and with and Western Western were and treated as for For culture Western were in and treated the in with 6-OHDA MPP+ J. J. PubMed Google Scholar). were and and were and were with and in with and for cell was by and the protein of cell was by the protein of protein were and to CHOP/Gadd153 and and were from and were from Cell with and Cell protein were and by and were a of a were treated with 6-OHDA MPP+ and with in culture were a of in were treated with 6-OHDA MPP+, and with in were with together with the dopaminergic TH, with and and were were an was used for The of and was by as and multiple Cell by 6-OHDA and by of have cell death as a whereas cell death of and of D. S. N. M. R. 2001; PubMed Scopus Google Scholar, J. PubMed Scopus Google Scholar, J. J. PubMed Google Scholar, A. 2002; PubMed Scopus Google Scholar). of and cell death of cell death proteins C. Johnson J. Neurochem. 2002; PubMed Scopus Google Scholar, S. G. H. S. Cell 2002; PubMed Scopus (61) Google Scholar), whereas not P. M. L. Full Text Full Text PDF PubMed Scopus Google Scholar, A. M. H. E. PubMed Scopus Google Scholar). cell death were treated with the protein of together with 6-OHDA MPP+ In of neurotoxin in cell death in a 6-OHDA an of cell death and MPP+ both of cell death protein may be to changes in gene associated with the cell death Microarray in 6-OHDA and analysis was used to the of a large number of of the genes and the of were as by the analysis for of were as present for were subsequently by toxin by both 6-OHDA and MPP+ 6-OHDA three as as MPP+. increased in response to 6-OHDA, whereas only increased in response to MPP+. for were not Both neurotoxins induced a number of the with of the induced by MPP+ also induced by 6-OHDA genes involved in cell and transcription cell death The induced in response to was that to the stress protein 6-OHDA also induced a large number of that were by MPP+ including molecular chaperones and genes involved in protein and the ubiquitin-proteasome pathway support that MPP+ and 6-OHDA of cell increased by both 6-OHDA and MPP+ of increased by both 6-OHDA and transcription factor protein response gene protein and transcription factor initiation factor protein protein in a increased by 6-OHDA only of increased by 6-OHDA, but not by protein protein protein protein S. protein protein S. C-terminal hydrolase in a in to 6-OHDA and the that was up-regulated by 6-OHDA and MPP+ in was 6-OHDA induced a large and of that and MPP+ of that of 6-OHDA, but to for and are with the from a with 6-OHDA with MPP+ and Western of cell that levels of protein were also and 6-OHDA induced a and more in protein MPP+ in treated were and whereas both 6-OHDA and MPP+ treated is with the role of as a transcription factor. these and the that toxin of dopaminergic leads to an of and protein of by 6-OHDA and is up-regulated by a of including ER stress N. Mol. 1997; PubMed Scopus Google Scholar, A. A. L. D. Genes PubMed Scopus Google Scholar, H. M. N. H. D. Genes 1998; PubMed Scopus Google Scholar, C. A. M. D. P. PubMed Scopus Google Scholar). of further analysis of revealed a of of stress-induced genes including involved in UPR and molecular chaperones such as and transcription factors and the role that UPR may play in 6-OHDA and MPP+ of these was by and is an protein to UPR A. Y. L.M. D. Nat. Cell Biol. 2000; PubMed Scopus Google Scholar). of were increased from to 6-OHDA in response to MPP+ were with for both 6-OHDA and MPP+ Although not to ER of the c-Jun N-terminal protein pathway UPR A. Y. P. D. Science. 2000; PubMed Scopus Google Scholar, S. D. 18: PubMed Scopus Google Scholar). of c-Jun was increased by 6-OHDA and levels that of from to MPP+ in a of c-Jun to that of to to MPP+ of c-Jun was not and to levels by of the UPR pathway is the of of Xbp1 by the ER of ER stress M. H. D. Nature. 2002; PubMed Scopus Google Scholar, K. W. M. R. T. H. K. Genes 2002; PubMed Scopus Google Scholar). levels of Xbp1 are also increased by ER In response to 6-OHDA but not MPP+, Xbp1 was induced to the analysis Xbp1 was the of Xbp1 were used to a in of the in 6-OHDA a of processed Xbp1 and to levels In MPP+ in a inhibition of Xbp1 processing from to Western of by 6-OHDA and of the UPR pathway not only transcriptional but also involvement of protein such pathway is that of of which leads to phosphorylation of c-Jun A. Y. P. D. Science. 2000; PubMed Scopus Google Scholar, S. D. 18: PubMed Scopus Google Scholar). In to changes in c-Jun and Western analysis that 6-OHDA increased phosphorylation of c-Jun levels and In with MPP+ induced a of c-Jun to levels by are with the a MPP+ mediated in c-Jun that was not and Taken together these that to 6-OHDA to the of the of UPR is by phosphorylation of by the ER Western revealed that both and in phosphorylation and MPP+ induced a whereas 6-OHDA in phosphorylation of from to The PERK is by and Western that MPP+ induced PERK phosphorylation in a to In PERK phosphorylation induced by 6-OHDA levels for and the protein levels a with 6-OHDA but not with MPP+ with both and In with reports that 6-OHDA induced J. PubMed Scopus Google Scholar, J. J. PubMed Google Scholar), but MPP+ was only in these that of UPR, including multiple were up-regulated in response to 6-OHDA In with MPP+ to the of but not of Thus, MPP+ may to dopaminergic cell death by a pathway that is of 6-OHDA, but MPP+, of the UPR in UPR be in neurotoxin Western analysis and were to from the dopaminergic 6-OHDA increased levels of protein and 6-OHDA also increased phosphorylation of and c-Jun. In of the in the dopaminergic cell were up-regulated in treated with MPP+. 6-OHDA MPP+ induced changes in levels of protein not of with and dopaminergic neurons to be examined with of in both dopaminergic neurons as well as in cell treated with MPP+ not appear from in of was in dopaminergic neurons a increased of was with 6-OHDA in both dopaminergic and whereas was in phosphorylation of c-Jun MPP+ Taken together, these that MPP+ a UPR response in the cell but not in dopaminergic In 6-OHDA a of UPR in both as well as in dopaminergic Thus, these as a in the and molecular associated with 6-OHDA evidence suggests that ER stress induced by aberrant protein degradation a role in PD. with a to transcriptional in a well of 6-OHDA and MPP+ the present study identified changes in genes associated with a major of the UPR pathway, the transcription factor was dramatically up-regulated both the and protein levels by 6-OHDA MPP+. 6-OHDA of UPR including BiP, of Xbp1 the pathway, as well as proteins involved in the of such as PERK and In MPP+ restricted to associated with PERK and In of these cell 6-OHDA also UPR in of dopaminergic these that 6-OHDA and MPP+ cell death Inasmuch as 6-OHDA is widely used to models of PD, the present further support the notion that ER stress and ubiquitin-proteasome dysfunction is associated with this disorder. with PD stress and dysfunction have been implicated in PD J. 2000; Google Scholar). Because of two neurotoxins dopaminergic 6-OHDA and MPP+, are used to 6-OHDA is a of oxidative stress that be from dopamine D. S. N. M. R. 2001; PubMed Scopus Google Scholar). including 6-OHDA have been in PD M. B. J. J. PubMed Scopus Google Scholar, B. E. A. 25: PubMed Scopus Google Scholar, Jenner P. S.E. B. J. Neurochem. 1998; PubMed Scopus Google Scholar), dopamine as a factor in this disorder. was identified because to PD P. Science. PubMed Scopus Google Scholar, N. J. PubMed Scopus Google Scholar). MPTP, and MPP+, are also to oxidative stress in to function S. 2002; PubMed Scopus Google Scholar). The that mutations in α-synuclein (2Polymeropoulos M.H. Lavedan C. Leroy E. Ide S.E. Dehejia A. Dutra A. Pike B. Root H. Rubenstein J. Boyer R. Stenroos E.S. Chandrasekharappa S. Athanassiadou A. Papapetropoulos T. Johnson W.G. Lazzarini A.M. Duvoisin R.C. Di Iorio G. Golbe L.I. Nussbaum R.L. Science. 1997; 276: 2045-2047Crossref PubMed Scopus (6556) Google Scholar, 3Kreuger R. Kuhn W. Meuller T. Woitalla D. Graeber M. Keosel S. Przuntek H. Epplen J.T. Scheols L. Riess O. Nat. Genet. 1998; 18: 106-108Crossref PubMed Scopus (3280) Google Scholar), and (5Kitada T. Asakawa S. Hattori N. Matsumine H. Yamamura Y. Minoshima S. Yokochi M. Mizuno Y. Shimizu N. Nature. 1998; 392: 605-608Crossref PubMed Scopus (4140) Google Scholar, E. Boyer R. Auburger G. Leube B. Ulm G. Mezey E. Harta G. Brownstein M.J. Jonnalagada S. Chernova T. Dehejia A. Lavedan C. Gasser T. Steinbach P.J. Wilkinson K.D. Polymeropoulos M.H. Nature. 1998; 395: 451-452Crossref PubMed Scopus (1372) Google Scholar, N. T. Matsumine H. Asakawa S. Yamamura Y. H. T. Yokochi M. M. A. T. S. S. Shimizu N. Mizuno Y. 1998; PubMed Scopus Google Scholar, M.J. PubMed Google Scholar) are associated with PD to the that protein degradation is also an factor in this disorder. is the is these The present study gene to of genes to a more of the molecular by dopaminergic in response to 6-OHDA and MPP+. from this study the of a these oxidative stress and of ER as well as the of a of transcriptional changes associated with The the of cell death in response to 6-OHDA MPP+. in response to 6-OHDA and MPP+ is by the that the induced by toxin was a stress-induced transcription factor implicated in cell death H. M. N. H. D. Genes 1998; PubMed Scopus Google Scholar, K.D. Mol. Cell. Biol. 2001; PubMed Scopus Google Scholar). The and of was and by Western and In support of the present analysis of also in an of with a more C. J. 2002; PubMed Scopus Google Scholar). analysis of the dopaminergic cell revealed of stress MPP+ H. J. Neurochem. 2001; PubMed Scopus Google Scholar). this is the that 6-OHDA and that to a MPP+. identified analysis revealed that 6-OHDA induced a large number of genes that were not by MPP+, of which were involved in protein degradation In the of genes induced by both and stress-induced transcription factors number of genes was induced by MPP+ but not protein and transcription factor the of these changes is to a of genes induced by UPR pathways have been associated with UPR that are by the ER proteins, and PERK Y. L.M. Cell. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). The pathway is to the pathway, as well as Xbp1 A. Y. P. D. Science. 2000; PubMed Scopus Google Scholar, M. H. D. Nature. 2002; PubMed Scopus Google Scholar, K. W. M. R. T. H. K. Genes 2002; PubMed Scopus Google Scholar, T. K. K. D. T. M. J. Biol. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar). of to the leads to the of Xbp1 as well as ER chaperones Y. L.M. Cell. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar, T. H. R. M. K. J. 2002; PubMed Scopus Google Scholar). Finally, in to transcriptional ER protein phosphorylation of PERK activity Y. L.M. Cell. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). is in these For example, be up-regulated by both the and PERK pathways T. H. R. M. K. J. 2002; PubMed Scopus Google Scholar, Y. L.M. J. Mol. Biol. 2002; PubMed Scopus Google Scholar). as well as proteins, a the ER stress in In the to ER stress In a second the response that is by the transcription factors and is is by PERK Y. L.M. Cell. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar) D. M. Lee K. Nat. Mol. Cell. Biol. 2002; PubMed Scopus Google Scholar, 2001; Google Scholar). Thus, PERK also leads to the of analysis that of the genes induced by MPP+ 6-OHDA were increased to a was that 6-OHDA induced with with MPP+ both neurotoxins increased and only 6-OHDA increased levels are with the notion that 6-OHDA both and PERK pathways to the of the processing of Xbp1 of the pathway, was only with Although present have evidence that is not 6-OHDA but not MPP+ also dramatically up-regulated c-Jun and increased levels Taken together, to that 6-OHDA is three of the UPR and PERK, whereas MPP+ is only the PERK these is shown in support for this from that also be by such as in response to D. M. Lee K. Nat. Mol. Cell. Biol. 2002; PubMed Scopus Google Scholar) in response to 2001; Google Scholar). Thus, phosphorylation of not of the UPR and to of genes of but not T. H. R. M. K. J. 2002; PubMed Scopus Google Scholar, Y. L.M. J. Mol. Biol. 2002; PubMed Scopus Google Scholar). The present are with the that MPP+ phosphorylation and are to a recent that of to the of a of UPR T. S. W. Mol. 2002; PubMed Google Scholar). Thus, cell death that for toxin Cell and have shown 6-OHDA and MPP+ both oxidative only 6-OHDA in of and changes associated with J. PubMed Scopus Google Scholar, J. J. PubMed Google Scholar). of evidence from this that 6-OHDA not an For example, of the not cell death in the cell in dopaminergic neurons Y. S. M. PubMed Scopus Google Scholar, J. Google Scholar). of the not dopamine neurons from 6-OHDA J. Google Scholar), was protein to the in response to this A. and K. L. Finally, analysis to of proteins to of the pathway, were Thus, these support a in which 6-OHDA the is that 6-OHDA the pathway death such as and the of The pathway of protein A. M. H. E. PubMed Scopus Google Scholar, K. Takahashi A. S. H. S. K. T. M. PubMed Google Scholar, C. S. C. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar) as well as C. 2001; PubMed Scopus Google Scholar). of the pathway death proteins such as as well as of and H. Science. 2002; PubMed Scopus Google Scholar). In the of of the pathway because was protein were not identified by and death factor and A. L. V.M. 2000; PubMed Scopus Google Scholar) as well as death were not In a of evidence that ER stress of both and pathway factors and S. H. M. G. J. Biol. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar, N. K. H. T. Y. J. Biol. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). mediated by 6-OHDA to have more in with this pathway, the involvement of and remains to be The present as well as J. PubMed Scopus Google Scholar, J. J. PubMed Google Scholar) to order and the neurotoxin of dopaminergic neurons have shown that 6-OHDA induced an in J. J. PubMed Google Scholar). The that 6-OHDA leads to the of c-Jun and processed Xbp1 are increased and by is the phosphorylation of eIF2α, which is also increased significantly and for the by the a second of transcriptional by and The are and of c-Jun also this an in levels of increased protein is In phosphorylation of PERK is not 6-OHDA The to in this study was the of which was and only increased significantly have shown that the 6-OHDA in J. PubMed Scopus Google Scholar) and that the is in dopaminergic neurons J. J. PubMed Google Scholar). Thus, a of and dopaminergic cell death. and levels to levels of whereas these proteins in response to are MPP+ mediated changes is both toxins the response as a of oxidative this response as MPP+ more only to the and Xbp1 not significantly MPP+ but were induced by that the two are from the In the 6-OHDA and MPP+ to be more of UPR in were also in In MPP+ not appear to to c-Jun in dopaminergic neurons be to this is the of and of the in which the were the by which PD is to this of the pathways by which 6-OHDA and MPP+ The that 6-OHDA and MPP+ of the UPR pathway to a of the of these in models of degeneration and the of the In from cell death may also contribute such as support the role of ubiquitin-proteasome system dysfunction in PD, and a oxidative and protein M. for of and as well as the J. of and in for the of the which and of The is in by of
42
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Mihael H. Polymeropoulos, Christian Lavedan, Elisabeth Leroy et al. · Science · 1997 · 8.2K citations
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Tohru Kitada, Shuichi Asakawa, Nobutaka Hattori et al. · Nature · 1998 · 5.2K citations
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
J. William Langston, Philip L. Ballard, James W. Tetrud et al. · Science · 1983 · 4.9K citations